Potency of different red light sources in photodynamic induction of cell death in a squamous cell carcinoma cell line

被引:9
作者
Novak, Ben [1 ]
Peteja, Monika [2 ]
Brueck, Thomas [3 ]
Luebbert, Hermann [2 ]
机构
[1] Biofrontera Pharma GmbH, Hemmelrather Weg 201, D-51377 Leverkusen, Germany
[2] Biofrontera AG, Hemmelrather Weg 201, D-51377 Leverkusen, Germany
[3] Scemtec Sensor Technol, Gewerbeparkstr 20, D-51580 Reichshof, Germany
关键词
Photodynamic therapy; Light sources; Cell death; Squamous cell carcinoma; CONTROLLED PHASE-III; ACTINIC KERATOSIS; BF-200; ALA; 5-AMINOLEVULINIC ACID; IN-VITRO; THERAPY; PLACEBO; BLIND;
D O I
10.1016/j.pdpdt.2016.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LED illumination systems were found to be more efficacious than broad spectrum lamps in recent phase III trials on photodynamic treatment of actinic keratosis. However, a detailed comparison of the light doses emitted at the appropriate spectral range and its correlation to photodynamic effects is thus far not available for the most frequently used devices. Here, we compared the spectral emissions of three different PDT lamps with their potency of inducing cell death in ALA-loaded A431 cells, including a new system equipped with more advanced LEDs matching the photosensitizer absorption peak more precisely and emitting more homogeneous light over time. Cells were exposed to two different ALA concentrations, incubated for 1 or 3 h and then illuminated by one of two different LED or a broad-spectrum system at four different light doses, whereupon viability was assessed. Maximal doses were selected in accordance to clinically applied light doses in recent phase III studies and the manufacturers' recommendations. The data gathered here clearly demonstrate that the two LED systems were significantly more effective in inducing cell death than the broad spectrum system. Most efficient was the newer LED system, in agreement with emission parameters that more accurately corresponded to the photosensitizer's absorption peak. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:128 / 130
页数:3
相关论文
共 8 条
  • [1] In vitro and in vivo comparison of two different light sources for topical photodynamic therapy
    Babilas, P
    Kohl, E
    Maisch, T
    Bäcker, H
    Gross, B
    Branzan, AL
    Bäumler, W
    Landthaler, M
    Karrer, S
    Szeimies, RM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (04) : 712 - 718
  • [2] Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
    Dirschka, T.
    Radny, P.
    Dominicus, R.
    Mensing, H.
    Bruening, H.
    Jenne, L.
    Karl, L.
    Sebastian, M.
    Oster-Schmidt, C.
    Kloevekorn, W.
    Reinhold, U.
    Tanner, M.
    Groene, D.
    Deichmann, M.
    Simon, M.
    Huebinger, F.
    Hofbauer, G.
    Kraehn-Senftleben, G.
    Borrosch, F.
    Reich, K.
    Berking, C.
    Wolf, P.
    Lehmann, P.
    Moers-Carpi, M.
    Hoenigsmann, H.
    Wernicke-Panten, K.
    Hahn, S.
    Pabst, G.
    Voss, D.
    Foguet, M.
    Schmitz, B.
    Luebbert, H.
    Szeimies, R. -M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) : 825 - 836
  • [3] Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
    Dirschka, T.
    Radny, P.
    Dominicus, R.
    Mensing, H.
    Bruening, H.
    Jenne, L.
    Karl, L.
    Sebastian, M.
    Oster-Schmidt, C.
    Kloevekorn, W.
    Reinhold, U.
    Tanner, M.
    Groene, D.
    Deichmann, M.
    Simon, M.
    Huebinger, F.
    Hofbauer, G.
    Kraehn-Senftleben, G.
    Borrosch, F.
    Reich, K.
    Berking, C.
    Wolf, P.
    Lehmann, P.
    Moers-Carpi, M.
    Hoenigsmann, H.
    Wernicke-Panten, K.
    Helwig, C.
    Foguet, M.
    Schmitz, B.
    Luebbert, H.
    Szeimies, R. -M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) : 137 - 146
  • [4] Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
    Juzeniene, A
    Juzenas, P
    Ma, LW
    Iani, V
    Moan, J
    [J]. LASERS IN MEDICAL SCIENCE, 2004, 19 (03) : 139 - 149
  • [5] Intense Pulse Light and 5-ALA PDT: Phototoxic Effects In Vitro Depend on the Spectral Overlap With Protoporphyrine IX But Do Not Match Cut-Off Filter Notations
    Maisch, Tim
    Moor, Anne C. E.
    Regensburger, Johannes
    Ortland, Christoph
    Szeimies, Rolf-Markus
    Baeumler, Wolfgang
    [J]. LASERS IN SURGERY AND MEDICINE, 2011, 43 (02) : 176 - 182
  • [6] Choice of the proper wavelength for photochemotherapy
    Moan, J
    Iani, V
    Ma, LW
    [J]. PHOTOCHEMOTHERAPY: PHOTODYNAMIC THERAPY AND OTHER MODALITIES, PROCEEDINGS OF, 1996, 2625 : 544 - 549
  • [7] Comparison of the uptake of 5-aminolevulinic acid and its methyl ester in keratinocytes and skin
    Schulten, R.
    Novak, B.
    Schmitz, B.
    Luebbert, H.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (10) : 969 - 979
  • [8] Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study
    Szeimies, R. -M.
    Radny, P.
    Sebastian, M.
    Borrosch, F.
    Dirschka, T.
    Kraehn-Senftleben, G.
    Reich, K.
    Pabst, G.
    Voss, D.
    Foguet, M.
    Gahlmann, R.
    Luebbert, H.
    Reinhold, U.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) : 386 - 394